Summary of Significant Accounting Policies (Details) - Schedule of Antidilutive Due to the Net Loss - shares	12 Months Ended
Dec. 31, 2023	Dec. 31, 2022
Stock options [Member]
Equivalent common shares
Equivalent common shares	175,686	117,228
Warrants [Member]
Equivalent common shares
Equivalent common shares	1,843	1,843
Unvested restricted stock awards [Member]
Equivalent common shares
Equivalent common shares		23

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration